News

BLMs4BU shares its experience at a workshop on RNA-based approaches to assess mycobacterial viability

On 9-10 September 2026, a two-day workshop was held at the Institute of Tropical Medicine Antwerp (Belgium), bringing together researchers working on tuberculosis, leprosy and Buruli ulcer to exchange experiences on RNA-based approaches for assessing mycobacterial viability and identifying potential biomarkers of treatment response.

BLMs4BU presents new advances in Buruli ulcer diagnosis and research at the SEMTSI 2026 Congress

Representatives of the institutions involved in BLMs4BU shared studies linked to the clinical trial, including research by the University of Zaragoza aimed at improving the molecular confirmation of suspected Buruli ulcer cases.

Mission de supervision BLMs4BU au Togo : Un pas de plus vers un traitement plus court de l’Ulcère de Buruli

Durant quatre jours intenses, une délégation de l’Institut de Santé Carlos III et l’Université de Saragosse a rejoint la DAHW Togo ainsi que le Programme National des Maladies Tropicales Négligées (PNMTN) pour une mission de supervision stratégique dans le cadre de l’essai clinique.

Major Milestone: Recruitment completed for first clinical trial of shorter Buruli Ulcer treatment in Benin

The BLMs4BU Consortium is proud to announce a significant achievement: after four years of dedicated effort, participant recruitment for its first clinical trial in Benin has been successfully completed.

Empowering the molecular diagnosis network and enhancing diagnostic harmonization in BLMs4BU

Over the past two weeks, the BLMs4BU consortium has carried out an intensive series of activities across the clinical trial sites and partner institutions, strengthening both the scientific and collaborative foundations of the project.

BLMs4BU showcases advances in Buruli Ulcer research at ECTMIH 2025

Under the theme “Better Health For All In A Changing World”, the European Congress on Tropical Medicine and International Health (ECTMIH) celebrated their 30th anniversary in Hamburg, Netherlands, on 29 September-2 October 2025.

BLMs4BU Consortium at the 2nd WHO Global Meeting on Neglected Tropical Diseases

The 2nd Global Meeting on Cutaneous Neglected Tropical Diseases (NTDs), held 24-26 March 2025 in Geneva, Switzerland, was well represented by the BLMs4BU Consortium.

BLMs4BU Consortium Meeting in Benin: sharing the progress of the clinical trial and exchange of experiences in the team

On February 20-21, 2025, around 50-60 representatives from various international organizations, clinical staff, and researchers gathered in Benin to strengthen collaboration within the BLMs4BU Consortium, dedicated to the research and improvement of Buruli ulcer treatment.

The BLMs4BU consortium presents an update on the clinical trial activities to the 3rd International Mycobacterium ulcerans Conference

The BLMs4BU consortium showcased cutting-edge research and advancements in Buruli ulcer (BU) treatment.

July highlights from the BLMs4BU project: We actively participated in the skin NTD-LABNET meeting in Madrid and launched a new sub-study in Côte d’Ivoire to explore Buruli ulcer patients’ journey and access barriers

Isra Cruz, member of the WHO Diagnostic Technical Advisory Group for NTDs and lead data manager of the BLMs4BU Consortium, hosted at the Instituto de Salud Carlos III (Madrid, Spain) a new meeting of the Skin NTD-LABNET (8-10 July).

Categories